Clinical Trials Logo

Clinical Trial Summary

Patient with chronic wounds are selected to receive NATROX system ; it's a continous diffusion of oxygen therapy delivery system. This one is put on the wound during a consultation at the hospital and will be followed in home medical care. Every 2 days a nurse renew the application at home and patient recharge the system with oxygen every day. The complete treatment is prescribe for 4 weeks and at the end patient comes to hospital to have a consultation with the doctor.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03200353
Study type Interventional
Source Groupe Hospitalier Paris Saint Joseph
Contact
Status Active, not recruiting
Phase N/A
Start date April 10, 2017
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Terminated NCT05234632 - Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds N/A
Recruiting NCT04652531 - Autologous Serum-derived EV for Venous Trophic Lesions Not Responsive to Conventional Treatments N/A
Recruiting NCT05890703 - Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream Phase 2
Completed NCT06400875 - Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU